Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Tatsuhiko Miyazaki’s research bridges immunology, urologic oncology, and diagnostic innovation, with a focus on improving detection and risk stratification in cancer and autoimmune disease. His most cited work, “Evaluating the Role of Rheumatoid Factors for the Development of Rheumatoid Arthritis in a Mouse Model with a Newly Established ELISA System” (2010, 18 citations), introduces a streamlined ELISA platform to quantify autoantibodies, overcoming traditional purification hurdles and enabling more efficient screening for rheumatoid arthritis. In urology, Dr. Miyazaki has contributed critical case reports on rare malignancies, including the first comprehensive review of solitary fibrous tumors of the prostate (2021, 10 citations) and a fulminant case of leptomeningeal carcinomatosis in bladder cancer (2021, 6 citations), highlighting aggressive disease courses after definitive therapy. His recent work on clinical predictors of Grade Group upgrading from needle biopsy to radical prostatectomy specimens (2022, 3 citations) aids in refining treatment decisions for prostate cancer. Through these contributions, Dr. Miyazaki advances both basic immunological assays and clinical management of genitourinary cancers, offering tools and insights that directly impact patient care and diagnostic accuracy.